# AIMOVIG
> **BLA761077** · Biologics License Application · Sponsor: AMGEN INC · Approved 2018-05-17
## Drug
- **FDA Application Number:** BLA761077
- **Application type:** Biologics License Application
- **Brand name:** AIMOVIG
- **Generic name:** ERENUMAB-AOOE
- **Active ingredients:** ERENUMAB-AOOE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMGEN INC
- **Manufacturer:** Amgen Inc
- **First approval:** 2018-05-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077)
---
*MORVS · CC0 1.0*